(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-enamide

ID: ALA5181694

PubChem CID: 168272889

Max Phase: Preclinical

Molecular Formula: C30H30FN9O3

Molecular Weight: 583.63

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOc1cc2ncnc(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2cc1NC(=O)/C(F)=C\[C@@H]1CCCN1C

Standard InChI:  InChI=1S/C30H30FN9O3/c1-4-42-26-13-23-21(12-24(26)37-30(41)22(31)11-20-6-5-9-39(20)3)29(33-15-32-23)36-19-7-8-25(18(2)10-19)43-28-14-27-38-35-17-40(27)16-34-28/h7-8,10-17,20H,4-6,9H2,1-3H3,(H,37,41)(H,32,33,36)/b22-11+/t20-/m0/s1

Standard InChI Key:  BQKAPRHCWWQTIM-OKFCBPFISA-N

Molfile:  

 
     RDKit          2D

 43 48  0  0  0  0  0  0  0  0999 V2000
   -1.7152   -0.6156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0007   -0.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2888   -0.6152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2888   -1.4404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9988   -1.8522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7152   -1.4441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4238   -0.2044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1387   -0.6168    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1406   -1.4379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4289   -1.8545    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4238    0.6208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1385    1.0333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1387    1.8586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8516    2.2693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5664    1.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5680    1.0354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8562    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8516    3.0945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2810    2.2692    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9957    1.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7103    2.2692    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4249    1.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4249    1.0314    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7103    0.6187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9957    1.0314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8818   -0.1882    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0381    0.4793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7024   -0.2745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4299   -0.2030    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1445   -0.6156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8592   -0.2030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1445   -1.4408    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5738   -0.6156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4299   -1.8567    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4299   -2.6819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1445   -3.0945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5738   -1.4408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9065   -1.9256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1614   -2.7101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9862   -2.7101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2410   -1.9256    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0381   -1.7120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8592    0.6221    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
  4 10  1  0
  7 11  1  0
 11 12  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 17 16  2  0
 12 17  1  0
 14 18  1  0
 15 19  1  0
 19 20  1  0
 21 20  1  0
 22 21  2  0
 23 22  1  0
 24 23  1  0
 25 24  1  0
 20 25  2  0
 24 26  2  0
 23 27  1  0
 27 28  2  0
 28 26  1  0
  1 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  2  0
 31 33  2  0
  6 34  1  0
 34 35  1  0
 35 36  1  0
 37 33  1  6
 38 37  1  0
 39 38  1  0
 40 39  1  0
 40 41  1  0
 41 37  1  0
 41 42  1  0
 31 43  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5181694

    ---

Associated Targets(Human)

ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-N87 (850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 583.63Molecular Weight (Monoisotopic): 583.2456AlogP: 5.20#Rotatable Bonds: 9
Polar Surface Area: 131.69Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 3HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.90CX Basic pKa: 8.16CX LogP: 3.10CX LogD: 2.26
Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.22Np Likeness Score: -1.29

References

1. Li D, Tu Y, Jin K, Duan L, Hong Y, Xu J, Chen N, Zhang Z, Zuo H, Gong W, Zhang J, Wang Q, Qian H, Wang X, Ke Y, Xia G..  (2022)  Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment.,  65  (7.0): [PMID:35319895] [10.1021/acs.jmedchem.1c00710]

Source